Secondary Logo

Journal Logo

Articles by David M. Burger

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?

Fillekes, Quirine; Mulenga, Veronica; Kabamba, Desiré; More

AIDS. 27(13):2111-2115, August 24th, 2013.

The pharmacokinetics, safety and efficacy of tenofovir and emtricitabine in HIV-1-infected pregnant women

Colbers, Angela P.H.; Hawkins, David A.; Gingelmaier, Andrea; More

AIDS. 27(5):739-748, March 13th, 2013.

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets

Fillekes, Quirine; Mulenga, Veronica; Kabamba, Desiré; More

AIDS. 26(14):1795-1800, September 10th, 2012.

Analysis of variation in plasma concentrations of nelfinavir and its active metabolite M8 in HIV-positive patients

Baede-van Dijk, Patricia A.; Hugen, Patricia W. H.; Verweij-van Wissen, Corrien P. W. G. M.; More

AIDS. 15(8):991-998, May 25th, 2001.

Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir

Praag, Rieneke M. E. van; Weverling, Gerrit J.; Portegies, Peter; More

AIDS. 14(9):1187-1194, June 16th, 2000.

Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)

Cohen Stuart, James W.T.; Schuurman, Rob; Burger, David M.; More

AIDS. 13(7):F53-F58, May 7th, 1999.